TRK-IN-15

TRK-IN-15

• CAS Number: 1365213-20-2
• UNSPSC Description: TRK-IN-15 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-15 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-55)[1].
• Target Antigen: Trk Receptor
• Type: Reference compound
• Related Pathways: Neuronal Signaling;Protein Tyrosine Kinase/RTK
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/trk-in-15.html
• Solubility: 10 mM in DMSO
• Smiles: CCNC(C1=CN=C2N1N=C(N3[C@](C4=CC(F)=CC=C4)([H])CCC3)C=C2)=O
• Molecular Weight: 353.39
• References & Citations: [1] Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported